Robert LeBoyer
Stock Analyst at Noble Capital Markets
(2.57)
# 1,348
Out of 4,479 analysts
14
Total ratings
30.77%
Success rate
9.68%
Average return
Main Sectors:
Top Industries:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNCY Unicycive Therapeutics | Initiates: Outperform | $6 | $0.48 | +1,150.00% | 1 | Feb 14, 2024 | |
| CVKD Cadrenal Therapeutics | Initiates: Outperform | $4 | $0.49 | +724.74% | 1 | Dec 18, 2023 | |
| ELDN Eledon Pharmaceuticals | Initiates: Outperform | $10 | $2.41 | +314.94% | 1 | Sep 27, 2023 | |
| GOVX GeoVax Labs | Initiates: Outperform | $90 | $3.31 | +2,619.03% | 1 | May 8, 2023 | |
| MAIA MAIA Biotechnology | Initiates: Outperform | $14 | $3.35 | +317.91% | 1 | Feb 21, 2023 | |
| TNXP Tonix Pharmaceuticals Holding | Initiates: Outperform | $3,840 | $0.74 | +520,931.21% | 1 | Apr 18, 2022 | |
| LCTX Lineage Cell Therapeutics | Initiates: Outperform | $8 | $0.93 | +758.28% | 1 | Aug 19, 2021 | |
| PSTV Plus Therapeutics | Initiates: Buy | n/a | $1.55 | - | 1 | Jan 25, 2021 | |
| BNTC Benitec Biopharma | Downgrades: Neutral | n/a | $8.70 | - | 1 | Oct 5, 2020 | |
| AVXL Anavex Life Sciences | Initiates: Buy | n/a | $4.13 | - | 1 | Sep 28, 2020 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $16,500 | $1.26 | +1,309,423.81% | 1 | Aug 24, 2020 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | n/a | $18.28 | - | 1 | Apr 10, 2018 | |
| NTRP NextTrip | Initiates: Buy | n/a | $1.97 | - | 2 | Mar 8, 2018 |
Unicycive Therapeutics
Feb 14, 2024
Initiates: Outperform
Price Target: $6
Current: $0.48
Upside: +1,150.00%
Cadrenal Therapeutics
Dec 18, 2023
Initiates: Outperform
Price Target: $4
Current: $0.49
Upside: +724.74%
Eledon Pharmaceuticals
Sep 27, 2023
Initiates: Outperform
Price Target: $10
Current: $2.41
Upside: +314.94%
GeoVax Labs
May 8, 2023
Initiates: Outperform
Price Target: $90
Current: $3.31
Upside: +2,619.03%
MAIA Biotechnology
Feb 21, 2023
Initiates: Outperform
Price Target: $14
Current: $3.35
Upside: +317.91%
Tonix Pharmaceuticals Holding
Apr 18, 2022
Initiates: Outperform
Price Target: $3,840
Current: $0.74
Upside: +520,931.21%
Lineage Cell Therapeutics
Aug 19, 2021
Initiates: Outperform
Price Target: $8
Current: $0.93
Upside: +758.28%
Plus Therapeutics
Jan 25, 2021
Initiates: Buy
Price Target: n/a
Current: $1.55
Upside: -
Benitec Biopharma
Oct 5, 2020
Downgrades: Neutral
Price Target: n/a
Current: $8.70
Upside: -
Anavex Life Sciences
Sep 28, 2020
Initiates: Buy
Price Target: n/a
Current: $4.13
Upside: -
CNS Pharmaceuticals
Aug 24, 2020
Initiates: Buy
Price Target: $16,500
Current: $1.26
Upside: +1,309,423.81%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: n/a
Current: $18.28
Upside: -
NextTrip
Mar 8, 2018
Initiates: Buy
Price Target: n/a
Current: $1.97
Upside: -